cbdMD (YCBD) Non-Current Deferred Tax Liability (2016 - 2021)
cbdMD (YCBD) posted Non-Current Deferred Tax Liability of $6.1 million for Q3 2021, up 4604.62% sequentially from $130000.0 in Q2 2021, and up 583.35% YoY from $895000.0 in Q3 2020.
cbdMD (YCBD) Non-Current Deferred Tax Liability (2016 - 2021) Analysis & Trends
cbdMD has reported Non-Current Deferred Tax Liability for 6 years, with the latest figure at $6.1 million in Q3 2021.
- Quarterly Non-Current Deferred Tax Liability rose 583.35% year-over-year to $6.1 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $6.1 million (up 583.35% YoY) and the FY2021 annual result came in at $6.1 million, up 583.35% from the prior year.
- Non-Current Deferred Tax Liability rose to $6.1 million in Q3 2021 per YCBD's latest filing, from $130000.0 in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $6.1 million in Q3 2021 and troughed at $15000.0 in Q4 2017.
- A 5-year average of $1.7 million and a median of $563000.0 in 2020 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2018 and 2020: Non-Current Deferred Tax Liability jumped 33206.67% in 2018, then tumbled 60.05% in 2020.
- Over 5 years, Non-Current Deferred Tax Liability stood at $15000.0 in 2017, then surged by 33206.67% to $5.0 million in 2018, then tumbled by 55.16% to $2.2 million in 2019, then plunged by 74.87% to $563000.0 in 2020, then soared by 986.32% to $6.1 million in 2021.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $6.1 million, $130000.0, and $27000.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 6.12 Mn |
| Sep 30, 2021 | 6.12 Mn |
| Jun 30, 2021 | 130,000.00 |
| Jun 30, 2021 | 130,000.00 |
| Mar 31, 2021 | 27,000.00 |
| Mar 31, 2021 | 27,000.00 |
| Dec 31, 2020 | 563,000.00 |
| Dec 31, 2020 | 563,000.00 |
| Sep 30, 2020 | 895,000.00 |
| Sep 30, 2020 | 895,000.00 |
| Sep 30, 2019 | 2.24 Mn |
| Sep 30, 2019 | 2.24 Mn |
| Jun 30, 2019 | 2.83 Mn |
| Jun 30, 2019 | 2.83 Mn |
| Mar 31, 2019 | 3.92 Mn |
| Mar 31, 2019 | 3.92 Mn |
| Dec 31, 2018 | 5.00 Mn |
| Dec 31, 2018 | 5.00 Mn |
| Sep 30, 2018 | 21,000.00 |
| Sep 30, 2018 | 21,000.00 |